Category Archives: Medical School

SASKATOON - Saskatchewan's medical school is being warned to shape up or be put on probation.

The committee that accredits Canada's medical schools has sent a warning letter to the University of Saskatchewan College of Medicine.

"This action indicates that there are areas of non-compliance that will, if not corrected promptly, seriously compromise the ability of the faculty to deliver a quality medical education program," wrote the Committee on Accreditation of Canadian Medical Schools.

The letter was dated July 2011, but was only now made public on the CBC Saskatchewan news website.

It notes that the warning of probation is confidential and said the school is not required to notify students.

Dr. William Albritton, dean of the college, said in an interview Thursday that faculty and students were told about the letter.

There are 130 standards applied to medical schools. Albritton said a fact-finding visit last year found the college is "weak or deficient" on 10 standards.

"The weaknesses were that our faculty didn't provide timely feedback to the students. You're expected to do this within a couple of weeks of the ending of the rotation," said Albritton.

"And busy people in a busy practice tend to delay those kinds of things. They don't see them as being quite as important as they actually are."

Albritton said instructors getting written standardized teaching and grading objectives is a problem. There's also concern around adequate student space for study, lounge and lockers at the Regina campus.

Read the rest here:
Saskatchewan's only medical school gets probation warning to shape up

KING OF PRUSSIA, Pa.--(BUSINESS WIRE)--

Theorem Clinical Research, a full-service contract research organization (CRO) that provides core clinical research and development services, is pleased to announce the appointment of Evan Rosenfeld, M.D., J.D., F.C.L.M., as vice president of medical and scientific affairs, Medical Device and Diagnostics.

Rosenfeld has more than ten years experience within the medical device and diagnostic industries as both an attorney and medical director.

Evan has a very dynamic background, stated Theorem Clinical Research Chief Executive Officer John Potthoff. He initially worked as a lawyer for medical device clients and then moved into chief medical officer roles within these companies after graduating from medical school. Evan understands this industry from both the legal and strategic leadership perspective, and he will be a great asset to our company.

A cum laude graduate of Harvard University, Rosenfeld also graduated cum laude from the University of Pennsylvania Law School. He later obtained his medical degree from the Medical College of Virginia/Virginia Commonwealth University.

Rosenfeld previously served as the medical director and senior consultant for regulatory and clinical affairs at Emergo Group Inc. At the same time, he founded MDJD Consulting and worked as an independent consultant providing medical, clinical and regulatory analysis, insights and strategic recommendations.

Rosenfeld has also worked as the chief medical officer/senior vice president of regulatory affairs at Microtransponder Inc. and as chief medical officer/vice president of medical and regulatory affairs at Bioness Inc.

Currently, he holds active physician licenses with the Texas Medical Board and the Medical Board of California. A fellow of the American College of Legal Medicine, Rosenfeld also holds membership with the Commonwealth of Pennsylvania Bar, the United States Patent and Trademark Office Bar, the District of Columbia Bar and the State of Illinois Bar.

About Theorem Clinical Research Theorem Clinical Research is one of the industrys leading full-service, contract research organizations (CRO). Before launching in 2011, Theorem Clinical Research operated for nearly two decades as Omnicare Clinical Research under the Omnicare Inc. parent company. A global organization with 1,000+ employees located throughout 27 countries, Theorem Clinical Research provides core CRO services for Phases I-IV, but with niche business units in the areas of technical services, medical devices and pharmaceutics with speed, flexibility and attention to detail to drive a high-quality performance. For more information, visit http://www.theoremclinical.com.

Continue reading here:
Theorem Clinical Research Announces Rosenfeld as Vice President of Medical and Scientific Affairs, Medical Device and ...

25-02-2012 12:51 WashU Med 2014 Second-Year Class Show. Produced by Hallie Morris, Philip Perez and David Rubins.

More:
The Ultimate Medical School Lecture - Video

Dennis S. Charney, MD, Dean of Mount Sinai School of Medicine, announced today that the school has received reaccreditation from the Liaison Committee on Medical Education (LCME), the premier authority responsible for accrediting all Medical Doctor (MD) programs in the United States and Canada. Mount Sinai was reaccredited for the maximum term of eight years.

New York, NY (PRWEB) March 19, 2012

Medical schools must demonstrate compliance with LCME standards in five areas: institutional and educational programs, medical students, faculty, and educational resources. Only LCME-accredited institutions may receive federal grants for medical education and participate in federal loan programs. Through accreditation, the LCME assures medical students and graduates, members of the medical profession, health care institutions, and the public that MD programs meet the highest educational standards and that graduates of these medical schools have complete educational experience sufficient to prepare them for the next stage of their training.

We are very pleased to have met the high standards of the LCME in securing reaccreditation for our MD program, said Dr. Charney. Considering how much of a challenge this designation has been for medical schools across the country, we are proud of the hard work and dedication of David Muller, MD, Dean of Medical Education, and our faculty, staff, and students, in achieving it.

The accreditation process consists of a rigorous self-assessment, a four-day site visit from a panel of LCME reviewers, and completion of a student survey, which is then reviewed by the LCME panel. The self-assessment is completed over a two- to three-month period during which the medical school must compile a comprehensive database from the findings to be evaluated by the LCME reviewers.

Mount Sinai School of Medicine created a steering committee and several task forces, which were responsible for each of the five areas of review. Led by Dr. Muller, preparations for the site visit began nearly two years ago and involved the participation of hundreds of faculty, staff, and students.

The entire Mount Sinai student body was surveyed, which helped inform the reaccreditation process. Seven committees of nearly 175 faculty staff and students met weekly for four months to prepare for the site visit. The steering committee issued a bi-weekly communiqu and held monthly town hall meetings throughout the process to keep the greater medical school community informed. Seventy-five representatives from all areas in the medical school met with the site visitors during a four-day visit, resulting in a successful program reaccreditation.

Seeing so many of our faculty and students collaborating to make this process a success has been a privilege, said Dr. Muller. I am delighted that the LCME has recognized Mount Sinai School of Medicine for our commitment to excellence in education.

About The Mount Sinai Medical Center

The Mount Sinai Medical Center encompasses both The Mount Sinai Hospital and Mount Sinai School of Medicine. Established in 1968, Mount Sinai School of Medicine is one of the leading medical schools in the United States. The Medical School is noted for innovation in education, biomedical research, clinical care delivery, and local and global community service. It has more than 3,400 faculty in 32 departments and 14 research institutes, and ranks among the top 20 medical schools both in National Institutes of Health (NIH) funding and by US News and World Report.

Read this article:
Mount Sinai School of Medicine Awarded Reaccreditation from the Liaison Committee on Medical Education

(Rowan University interim president Dr. Ali Houshmand, left, with Lawrence and Rita Salva and Cooper Medical School founding dean Dr. Paul Katz, right. Photo provided)

By Michelle Durham

CAMDEN, N.J. (CBS) Officials at the Cooper Medical School of Rowan University received a tremendous gift last week: more than $1 million, earmarked for scholarships to students of the new medical school.

The donation was made to the Rowan Foundation by Comcast Corporation Senior Vice President Lawrence Salva and his wife, Rita.

Salva is a Rowan University alumnus.

A million dollars will flow into an endowment that will permanently fund, annually, four-year scholarships to one or more students, he explains. (An) additional $55,000, combined with earnings from the endowment, will fund the initial grant of $100,000 in scholarships to the initial charter class.

That first class begins August 2012.

Dr. Paul Katz, dean of the medical school, says the average medical student has $160,000 of school debt by the time he or she graduates.

Anything we can do to allow students to have less of an impact on the career decisions they make based on finances is great, he tells KYW Newsradio.

Be the first to like this post.

See the original post here:
Rowan’s Medical School In Camden Gets $1M+ Scholarship Donation

10-02-2012 20:07 Time to practice: Medical students have many options available to them after graduation. Jeremy Levenstadt is a newly minted doctor. He sits down with Steve Paikin to discuss his career options.

The rest is here:
Jeremy Levenstadt: Options After Medical School - Video